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Methods
Twenty-one inpatients (15 males/6 females) with an aver-
age age of 23.7 years,who had been diagnosed with FEP
according to DSM-IV-TR (Diagnostic and Statistical
Manual of Mental Disorders,Fourth Edition,Text Revision)
criteria,were evaluated using the Positive and Negative
Syndrome Scale (PANSS). SPECT was acquired after
injection of 
99mTc-HMPAO (
99mTc-hexamethylpropyl-
eneamine oxime),before drug treatment and again after
3 months of treatment with either risperidone (mean dose
4.8 mg/day, in 7 patients with predominantly negative
symptoms), olanzapine (mean dose 11.6 mg/day, in 9
patients with predominantly positive symptoms),and que-
tiapine (mean dose 440 mg/day, in 5 patients with pre-
dominantly positive symptoms).
Exclusion criteria included the presence of a neurological
or other somatic disorder that could modify rCBF, and
previous exposure to antipsychotic drug treatment.
Results
Baseline SPECT assessments revealed a diffuse low per-
fusion in the left parietal and temporal cortices,and in
the right ventromedial frontal cortex, in 11 out of 14
patients with predominantly positive symptoms (Figures
1 and 2).In 6 out of 7 patients with predominantly nega-
Copyright © 2005 LLS SAS. All rights reserved
Figure 1. Baseline single photon emission computed tomography (SPECT)
shows reduced perfusion in the left parietal and temporal cortices
in 11 out of 14 patients with predominantly positive symptoms.
Figure 2. Baseline single photon emission computed tomography (SPECT)
shows reduced perfusion in the right ventromedial frontal cortex
in 11 out of 14 patients with predominantly positive symptoms. 
Single photon emission computed tomography (SPECT) is a valuable tool for evaluating
regional cerebral blood flow (rCBF) in patients with schizophrenia. Recently, various 
neuropharmacological studies using SPECT in patients with schizophrenia have also 
characterized dopamine D2 receptors, their correlation with symptoms, as well as receptor 
occupancy after treatment with atypical antipsychotics.
1,2 We studied changes in rCBF in 
first-episode psychosis (FEP) before and after pharmacological treatment.tive symptoms, we found a reduced perfusion in the
frontal cortex (though bilateral,this reduction was more
pronounced on the left side),decreased rCBF in the right
basal ganglia,and low perfusion in the left orbitofrontal
cortex (Figure 3).rCBF was normal in 4 patients (3 with
predominantly positive symptoms and 1 with predomi-
nantly negative symptoms).
The cortical abnormalities observed in patients at baseline
persisted after treatment. After treatment, additional
changes in subcortical structures were also observed,
notably an increase in rCBF in the left caudate nuclei in
14 patients (Figure 4).
3
Discussion
These results are consistent with the finding of Liddle et
al on rCBF patterns in schizophrenia,
4,5 who reported both
increases and decreases in rCBF, suggesting a dynamic
imbalance rather than a fixed abnormality.
Conclusion
Our data suggest cortical abnormalities in rCBF,at base-
line and after treatment,conceivably correlated with the
type of symptoms.Subcortical changes appearing during
treatment (notably in the left caudate nuclei) may be the
consequence of treatment,but not of any one specific drug
in particular. ❏
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Figure 3. Baseline single photon emission computed tomography (SPECT)
shows reduced perfusion in the frontal cortex and the left
orbitofrontal cortex and decreased regional cerebral blood flow
(rCBF) in the right basal ganglia, in 6 out of 7 patients with pre-
dominantly negative symptoms.
Figure 4. Single photon emission computed tomography (SPECT) after treat-
ment in 14 patients showed an increase in regional cerebral blood
flow (rCBF) in the left caudate nuclei.
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